Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;6(6):e169-77.
doi: 10.1111/j.1750-2659.2012.00408.x. Epub 2012 Jul 16.

Epidemiology of influenza A (H1N1)pdm09-associated deaths in the United States, September-October 2009

Collaborators, Affiliations

Epidemiology of influenza A (H1N1)pdm09-associated deaths in the United States, September-October 2009

Joanna Regan et al. Influenza Other Respir Viruses. 2012 Nov.

Abstract

Background: From April to July 2009, the United States experienced a wave of influenza A (H1N1)pdm09 virus (H1N1pdm09) infection. The majority of the deaths during that period occurred in persons <65 years of age with underlying medical conditions.

Objective: To describe the epidemiology of H1N1pdm09-associated deaths in the US during the fall of 2009.

Methods: We collected demographic, medical history, and cause of death information on a nationally representative, stratified random sample of 323 H1N1pdm09-associated deaths that occurred during September 1-October 31, 2009.

Results: Data were available for 302/323 (93%) deaths. Most cases (74%) were 18-64 years of age and had ≥ 1 underlying medical condition (72%). Among cases aged <18 years, 16/43 (37%) had a chronic lung disease, and 15/43 (35%) a neurological disorder; among cases aged ≥ 18 years, 94/254 (37%) had a chronic lung disease and 84/254 (33%) had a metabolic disorder. The median number of days between symptom onset and death was six among children (range, 1-48) and 12 among adults (range, 0-109). Influenza antiviral agents were prescribed for 187/268 (70%) of cases, but only 48/153 (31%) received treatment within 2 days of illness onset.

Conclusions: The characteristics of H1N1pdm09 deaths identified during the fall of 2009 were similar to those occurring April-July 2009. While most cases had conditions that were known to increase the risk for severe outcomes and were recommended to receive antiviral therapy, a minority of cases received antivirals early in the course of illness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Influenza A (H1N1)pdm09‐associated deaths, by age group, United States, September 1–October 31, 2009.

References

    1. Novel Swine‐Origin Influenza A (H1N1) Virus Investigation Team . Emergence of a novel swine‐origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605–2615. - PubMed
    1. Jhung M, Swerdlow D, Olsen S et al. Epidemiology of 2009 Pandemic Influenza A (H1N1) in the United States. Clin Infect Dis 2011; 52(Suppl 1):S13–S26. - PubMed
    1. Thompson WW, Shay DK, Weintraub E et al. Mortality associated with influenza viruses and respiratory syncytial virus in the United States. JAMA 2003; 289:170–186. - PubMed
    1. Centers for Disease Control and Prevention . Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58:1–54. - PubMed
    1. Fowlkes A, Arguin P, Biggerstaff M et al. Epidemiology of 2009 Pandemic Influenza A (H1N1) deaths in the United States, April–July 2009. Clin Infect Dis 2011; 52(Suppl 1):860–868. - PubMed

MeSH terms

Substances